Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2000
03/02/2000WO2000010527A1 Oral mucoadhesive compositions containing gastrointestinal actives
03/02/2000WO2000010526A2 New oral formulation for 5-ht4 agonists or antagonists
03/02/2000WO2000010516A1 Topical anionic salicylate for disorders of the skin
03/02/2000WO2000010507A2 Use of melanin for inhibition of angiogenesis and macular degeneration
03/02/2000WO2000010506A2 Angiogenesis inhibitors and uses thereof
03/02/2000WO2000010408A1 Food supplements comprising lipoic acid and creatine and methods for their use
03/02/2000WO2000010391A1 The use of adenosine a3 receptor antagonists to inhibit tumor growth
03/02/2000WO2000010389A1 BLOCKADE OF GLUCOSE TOXICITY TO THE β CELLS IN THE ISLETS OF LANGERHANS
03/02/2000WO2000010385A1 Method of enhancing catheter patency using a citrate salt catheter lock solution
03/02/2000WO1999065469A3 Processes to generate submicron particles of water-insoluble compounds
03/02/2000WO1999064409A3 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
03/02/2000WO1999064054A9 Multibinding inhibitors of topoisomerase
03/02/2000WO1999064043A9 Muscarinic receptor antagonists
03/02/2000WO1999063938A9 Composition and method for prevention and treatment of cardiopulmonary and renal failure or damage associated with ischemia, endotoxin release, ards or brought about by administration of certain drugs
03/02/2000WO1999063937A3 Multivalent macrolide antibiotics
03/02/2000WO1999062909A3 Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents
03/02/2000WO1999059640A3 Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
03/02/2000WO1999058555A3 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues
03/02/2000WO1999048483A8 (-)-phenylpropanolamine as a sympathomimetic drug
03/02/2000WO1999045108A3 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
03/02/2000WO1999042088A3 Method for the treatment of diseases or disorders of the inner ear
03/02/2000WO1999035912A8 Tuberculocidal disinfectant
03/02/2000WO1999011605A8 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
03/02/2000WO1998051662A3 Compounds and methods for the inhibition of the expression of vcam-1
03/02/2000DE19847633C1 Preparation of retinol-gamma cyclodextrin complex useful in skin care cosmetic or dermatological compositions comprises using retinol as solution in polysorbate, giving quantitative conversion to stable complex
03/02/2000DE19839499A1 2-Oxo-2H-chinolinderivate 2-oxo-2H-quinoline
03/02/2000DE19839443A1 Pharmaceutical and dietetic product contains quaternary ammonium compound and/or S-adenosyl-methionine, useful for treatment of oxygen deficiency and energy metabolism disorders and NSAID side effects
03/02/2000DE19839441A1 Pharmaceutical and dietetic product contains quaternary ammonium compound and/or S-adenosyl-methionine, useful for treatment of oxygen deficiency and energy metabolism disorders and NSAID side effects
03/02/2000DE19839337A1 Parenteral medicament for treating antithrombin III deficiency contains potent beta-isoform of antithrombin III
03/02/2000DE19838848A1 Pyrrolizidinalkaloidfreie Petasites enthaltende Zusammensetzung Pyrrolizidinalkaloidfreie Petasites containing composition
03/02/2000DE19838705A1 Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one New dihydro- (1,2,3) triazolo [4,5-d] pyrimidin-7-one
03/02/2000DE19838636A1 Carotinoid-Formulierungen, enthaltend ein Gemisch aus beta-Carotin, Lycopin und Lutein A carotenoid formulation comprising a mixture of beta-carotene, lycopene and lutein
03/02/2000DE19838542A1 Use of pentaerthrityl nitrate as cardiovascular drug, especially anti-angina agent, which can be used safely in presence of phosphodiesterase inhibitor
03/02/2000DE19838541A1 Safe combination preparation containing pentaerythrityl nitrate and phosphodiesterase inhibitor, useful for treating cardiovascular disorders and/or erectile dysfunction
03/02/2000DE19826517A1 Cyclophosphamid-Filmtabletten Cyclophosphamide tablets
03/02/2000DE19818914C2 Verwendung von peroxidierten organischen Verbindungen mit "aktiviertem Sauerstoff" zur Verbesserung der Mikrozirkulation des Blutes in der Haut Use of peroxidized organic compounds with "activated oxygen" to improve the microcirculation of blood in the skin
03/02/2000DE19814405C2 Porphyrine und ihre Verwendung als Photosensitizer Porphyrins and their use as photosensitizer
03/02/2000CA2664159A1 Carbonyl-stress improving agent and peritoneal dialysate
03/02/2000CA2342503A1 Quinazoline derivatives
03/02/2000CA2342162A1 Drug targeting
03/02/2000CA2341989A1 Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application
03/02/2000CA2341970A1 Compounds, compositions and methods for treating or preventing viral infections and associated diseases
03/02/2000CA2341903A1 Use of melanin for inhibition of angiogenesis and macular degeneration
03/02/2000CA2341742A1 Activation and protection of t-cells (cd4+ and cd8+) using an h2 receptor agonist and other t-cell activating agents
03/02/2000CA2341701A1 Medicament containing platinum complex compounds and the use thereof
03/02/2000CA2341673A1 Amelioration of apomorphine adverse effects
03/02/2000CA2341586A1 Targeting of molecules to large vessel endothelium using epcr
03/02/2000CA2341558A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
03/02/2000CA2341540A1 Inhibition and treatment of hepatitis b virus and flavivirus by helioxanthin and its analogs
03/02/2000CA2341531A1 Oxo-pyridoimidazole-carboxamides: gaba brain receptor ligands
03/02/2000CA2341530A1 Carbamate and urea compositions and neurotrophic uses
03/02/2000CA2341485A1 Timed release tablet comprising naproxen and pseudoephedrine
03/02/2000CA2341400A1 Methods and compositions employing optically pure s(+) vigabatrin
03/02/2000CA2341370A1 Novel substituted triazole compounds
03/02/2000CA2341357A1 Quinazoline derivatives and pharmaceutical applications therof
03/02/2000CA2341309A1 Use of mcrp for delivery of materials into cells
03/02/2000CA2341271A1 Novel isoxazolinone antibacterial agents
03/02/2000CA2341234A1 Water soluble analogs and prodrugs of paclitaxel
03/02/2000CA2341195A1 Prophylactic or therapeutic composition for ocular circulation disorders
03/02/2000CA2341191A1 New use of taxoid derivatives
03/02/2000CA2341028A1 Novel aryl sulphonamide amino acid esters and analogues
03/02/2000CA2340946A1 Muscarinic agonists and antagonists
03/02/2000CA2340928A1 Novel arylsulphonamides and analogues
03/02/2000CA2340649A1 Phosphoglycolipid and methods for its use
03/02/2000CA2340459A1 C-myc is activated by beta-catenin and tcf-4
03/02/2000CA2340344A1 Growth hormone secretagogues
03/02/2000CA2340133A1 Natural physiologically active substances efficacious against fish diseases and fish feeds containing the same
03/02/2000CA2339775A1 Vitamin d3 mimics
03/02/2000CA2339537A1 Regulation of substrate activity
03/02/2000CA2339372A1 New compounds
03/02/2000CA2339286A1 New compounds
03/02/2000CA2339036A1 Tpl-2/cot kinase and methods of use
03/02/2000CA2338688A1 Oral mucoadhesive compositions containing gastrointestinal actives
03/02/2000CA2337307A1 Quaternary ammonium salts and their use
03/02/2000CA2306747A1 Dinitroaniline liposomal formulations and processes for their preparation
03/02/2000CA2245254A1 Glycoside shampoo for treating psoriasis
03/01/2000EP0982832A2 Charging system for electric vehicle
03/01/2000EP0982400A1 Human glycine transporter
03/01/2000EP0982316A2 Preparation of sterol and stanol-esters
03/01/2000EP0982315A2 Preparation of sterol and stanol esters
03/01/2000EP0982308A1 Derivatives of the 8H-(2,3-b)-pyrrolizine-8-one, process for their preparation and pharmaceutical compositions containing them
03/01/2000EP0982307A2 9 -Amino- and 9-nitro-camptothecin derivatives, process for their preparation and use as antitumor agents
03/01/2000EP0982305A1 Indane-1-ol derivatives, process for their preparation and pharmaceutical compositions containing them
03/01/2000EP0982304A1 Piperidine derivatives having effects on serotonin related systems
03/01/2000EP0982302A2 Delta 6,7-taxols antineoplastic use and pharmaceutical compositions containing them
03/01/2000EP0982301A2 Delta 6,7-taxols antineoplastic use and pharmaceutical compositions containing them
03/01/2000EP0982300A2 Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
03/01/2000EP0982297A2 Process for the preparation of hydroxy-pyrrolidinyl hydroxamic acid derivatives being opioid kappa receptor agonists
03/01/2000EP0982033A2 Use for fructose-1,6-diphosphate (FDP) in the manufacture of medicaments
03/01/2000EP0982032A2 Use of a ring system compound comprising a sulphamic acid ester group for the manufacture of medicaments for the control of oestrogen production
03/01/2000EP0982031A2 Antifungal compositions comprising voriconazole and trovafloxacin or prodrugs thereof
03/01/2000EP0982030A2 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
03/01/2000EP0982029A1 Preventives/remedies for arteriosclerosis
03/01/2000EP0982028A1 New use of taxoid derivatives
03/01/2000EP0982027A1 Taxoid derivatives for treating abnormal cell proliferation of the brain
03/01/2000EP0982026A2 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers
03/01/2000EP0982025A1 Synthetic tear fluid
03/01/2000EP0981969A1 Carotinoid compositions comprising a mixture of beta-carotene, lycopene and lutein
03/01/2000EP0981967A1 Feed composition for broilers and method for breeding broilers
03/01/2000EP0981748A1 Signal enhancement of bispecific antibody-polymer probe for immunoassay use
1 ... 6355 6356 6357 6358 6359 6360 6361 6362 6363 6364 6365 6366 6367 6368 6369 6370 6371 6372 6373 6374 6375 ... 7860